X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-18 | ELV | Kendrick Charles Morgan Jr | EVP, Pres, Commercial | S - Sale | $432.14 | -7,417 | 8,423 | -47% | -$3,205,182 | ||||||
2024-08-05 | ELV | Peru Ramiro G | Dir | S - Sale | $531.52 | -753 | 8,744 | -8% | -$400,235 | ||||||
2024-07-22 | ELV | Boudreaux Gail | Pres, CEO | S - Sale | $500.98 | -34,000 | 126,769 | -21% | -$17,033,395 | ||||||
2024-07-19 | ELV | Dixon Robert L Jr | Dir | S - Sale | $506.76 | -305 | 9,721 | -3% | -$154,562 | ||||||
DM | 2024-04-23 | ELV | Norwood Felicia F | EVP, Pres,Gov Health Ben | S - Sale+OE | $533.34 | -20,310 | 27,304 | -43% | -$10,832,155 | |||||
2024-03-08 | ELV | Kendrick Charles Morgan Jr | EVP, Pres, Commercial | S - Sale | $500.46 | -2,432 | 15,840 | -13% | -$1,217,119 | ||||||
2024-03-06 | ELV | Penczek Ronald W | CAO, Controller | S - Sale | $504.58 | -916 | 1,764 | -34% | -$462,195 | ||||||
D | 2024-03-04 | ELV | Haytaian Peter D | EVP, Pres Carelon, CarelonRx | S - Sale+OE | $500.18 | -21,095 | 18,887 | -53% | -$10,551,297 | |||||
2024-02-07 | ELV | Peru Ramiro G | Dir | S - Sale | $500.00 | -753 | 9,109 | -8% | -$376,500 | ||||||
D | 2023-12-14 | ELV | Todt Blair Williams | EVP, CLO, CAO | S - Sale+OE | $484.02 | -5,492 | 12,512 | -31% | -$2,658,238 | |||||
2023-11-30 | ELV | Penczek Ronald W | CAO, Controller | S - Sale | $475.17 | -1,055 | 1,787 | -37% | -$501,304 | ||||||
2023-10-24 | ELV | Penczek Ronald W | CAO, Controller | S - Sale | $454.35 | -64 | 2,842 | -2% | -$29,078 | ||||||
2023-07-21 | ELV | Dixon Robert L Jr | Dir | S - Sale | $476.71 | -310 | 9,638 | -3% | -$147,780 | ||||||
2023-03-24 | ELV | McCarthy Gloria M | EVP, Chief Administrative Off | S - Sale | $444.76 | -15,098 | 51,435 | -23% | -$6,714,978 | ||||||
2023-03-09 | ELV | Kendrick Charles Morgan Jr | EVP, Pres, Commercial | S - Sale | $462.22 | -2,314 | 15,327 | -13% | -$1,069,577 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |